ProfileGDS4177 / 1569303_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 80% 73% 65% 62% 72% 72% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated207.1280
GSM603099KU-812 non-treated125.0873
GSM603098KCL-22 Imatinib-treated70.4865
GSM603097KCL-22 non-treated58.0462
GSM603102JURL-MK1 Imatinib-treated114.7872
GSM603101JURL-MK1 non-treated112.4772